ONIRON

Description

Composition: Ondansetron as the active ingredient.

Product Type: Tablet and Injectable Solution (IV/IM).

Quantity:
Tablets: 10tablets per pack
Injectable vials: Packaging typically includes single or multiple vials per box.

Strength/Dosage:
Tablet: 8 mg per tablet, typically taken orally.
Injection:4 mg/2 ml vial (2 ml per dose), 8 mg/4 ml vial (4 ml per dose).
Dosage depends on the condition being treated and patient-specific factors, as prescribed by a healthcare professional.

Indications:
Prevention of Nausea and Vomiting: Used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery.
Postoperative Nausea and Vomiting (PONV): Effective in controlling nausea and vomiting after surgical procedures.
Chemotherapy-Induced Nausea and Vomiting (CINV): Prevents both acute and delayed nausea caused by highly emetogenic chemotherapy regimens.
Radiation-Induced Nausea and Vomiting (RINV): Alleviates nausea and vomiting triggered by radiotherapy.
Rescue Therapy for Severe Vomiting: Can be used as a rescue treatment for persistent or severe nausea in various clinical settings.